Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

NCT02331498 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Pazopanib

Sponsor

Centre Antoine Lacassagne

Collaborators

[object Object]